The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum Disorders
Open accessAbstract
OBJECTIVE: The objective of this study was to provide national estimates of psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders and to examine child and health system characteristics associated with psychotropic medication use. METHODS: This cross-sectional study used Medicaid claims for calendar year 2001 from all 50 states and Washington, DC, to examine 60,641 children with an autism spectrum disorder diagnosis. Logistic regression with random effects was used to examine the child, county, and state factors associated with psychotropic medication use. RESULTS: Of the sample, 56% used at least 1 psychotropic medication, 20% of whom were prescribed > or = 3 medications concurrently. Use was common even in children aged 0 to 2 years (18%) and 3 to 5 years (32%). Neuroleptic drugs were the most common psychotropic class (31%), followed by antidepressants (25%) and stimulants (22%). In adjusted analyses, male, older, and white children; those who were in foster care or in the Medicaid disability category; those who received additional psychiatric diagnoses; and those who used more autism spectrum disorder services were more likely to have used psychotropic drugs. Children who had a diagnosis of autistic disorder or who lived in counties with a lower percentage of white residents or greater urban density were less likely to use such medications. CONCLUSIONS: Psychotropic medication use is common among even very young children with autism spectrum disorders. Factors unrelated to clinical presentation seem highly associated with prescribing practices. Given the limited evidence base, there is an urgent need to assess the risks, benefits, and costs of medication use and understand the local and national policies that affect medication use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mandell et al. reported that 56% were prescribed at least one psychotropic medication and 20% were prescribed three or more [27].”
From An Update on Psychopharmacological Treatment of Autism Spectrum Disorder (2022) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
The American Society of Health System Pharmacists
Beard, E. L. (2001) · JONA s Healthcare Law Ethics and Regulation · doi:10.1097/00128488-200109000-00003 · Cited by 1,685
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Epidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update
Fombonne, E. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025054610557 · Cited by 1,505
Prevalence of Autism in a US Metropolitan Area
Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003) · JAMA · doi:10.1001/jama.289.1.49 · Cited by 1,248
Factors Associated With Age of Diagnosis Among Children With Autism Spectrum Disorders
Mandell, D. S., Novak, M. M., & Zubritsky, C. D. (2005) · Pediatrics · doi:10.1542/peds.2005-0185 · Cited by 896
Self-citationInternational Classification of Diseases, Ninth Revision
National Cancer Institute (2020) · Definitions · doi:10.32388/bd1nux · Cited by 891
McEvoy, G. K. (1994) · Oncology Issues · doi:10.1080/10463356.1994.11904493 · Cited by 888
Trends in the Prescribing of Psychotropic Medications to Preschoolers
Zito, J. M. (2000) · JAMA · doi:10.1001/jama.283.8.1025 · Cited by 863
Research works printed but not linked: 1
- Bonferroni C. The calculation for the protection against groups of tests. In: Studies in Honor of Professor Salvatore Ortu Carboni. [in Italian] Rome, Italy;1935:13–60
Cited by
Sorted by citations
Items 201–295 of 295
Steever, M. P. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6510-3_11 · Cited by 4
Wilkins, J. W. (2010) · doi:10.31390/gradschool_dissertations.766 · Cited by 4
Ni, S.-Y., Lu, C., Wu, C., Hsieh, M.-H., Chen, I., Lin, C., Lai, F., & Chien, Y. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2025.11.026 · Cited by 4
Psychopharmacologic Considerations in Early Childhood
Finelli, J. M., & Gleason, M. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-10635-5_9 · Cited by 3
SEGURANÇA DA RISPERIDONA EM CRIANÇAS E ADOLESCENTES COM TRANSTORNO DO ESPECTRO AUTISTA
Neves, K. R. T., Albuquerque, I. M., Xavier, E. L. P., Martins, S. D. O., & Aragão, G. F. (2021) · Infarma - Ciências Farmacêuticas · doi:10.14450/2318-9312.v33.e2.a2021.pp138-148 · Cited by 2
Gender Trends in Psychotropic Medication Use in Autism
Huber, C. R., Fanaro, Z., & Soti, V. (2022) · Cureus · doi:10.7759/cureus.26447 · Cited by 3
Overview of autism interventions
Kang, E., McDonald, R. G., & White, S. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-816393-1.00004-x · Cited by 3
Ali, N. H., & Arbab, A. H. (2021) · ACTA Pharmaceutica Sciencia · doi:10.23893/1307-2080.aps.05917 · Cited by 3
Greydanus, D. E., Patel, D. R., & Rowland, D. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00085-2 · Cited by 3
Charlot, L. (2016) · Springer eBooks · doi:10.1007/978-3-319-18096-0_132 · Cited by 3
(2012) · PEDIATRICS · doi:10.1542/peds.2011-3285d · Cited by 3
Uygun, S. D., Çakmak, F. H., Canlı, M. A., Temeltürk, R. D., Efe, A., Gürel, Y., Açıkel, S. B., & Çetinkaya, M. (2020) · Journal of Child Science · doi:10.1055/s-0040-1721679 · Cited by 2
Association Between Neighborhood Context and Psychotropic Polypharmacy Use Among High-Need Children
Thomas, K. C., Annis, I. E., deJong, N. A., Christian, R. B., Davis, S., Hughes, P. M., Prichard, B. A., Prichard, J. R., Allen, P. S., Gettinger, J., et al. (2024) · Psychiatric Services · doi:10.1176/appi.ps.20230639 · Cited by 2
Özaydın, Y., Tatli, Ş., Özgür, B. G., & Aksu, H. (2024) · Çocuk ve Gençlik Ruh Sağlığı Dergisi / Turkish Journal of Child and Adolescent Mental Health · doi:10.4274/tjcamh.galenos.2024.26023 · Cited by 2
Predictors of Psychotropic Medication Use Among Autistic Adults
Mahé, O., Morel‐Kohlmeyer, S., Briend, F., & Houy‐Durand, E. (2025) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-025-06966-x · Cited by 2
Challenging Behaviors Associated with Autism and Pervasive Developmental Disabilities
Hendrix, N. M., & O’Brien, M. J. (2022) · Autism and child psychopathology series · doi:10.1007/978-3-030-88538-0_3 · Cited by 2
Karabacak, Y., Barun, S., Vural, İ. M., Vural, E. H., İşeri, E., Kahve, A. C., Yilmaz, E. Ş., İşli, F., Türkeş, S., Ezber, E., et al. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000456 · Cited by 2
The Prevalence of Psychiatric and Behavioral Comorbid Among Autistic adults
Vinola Shrim Mishma, S., & Shanmugam, A. (2024) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3242 · Cited by 2
Current Trends in the Pharmacological Treatment of Autism Spectrum Disorders
Kolevzon, A. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00006-5 · Cited by 2
Use of Medications in the Treatment of Aggressive Behavior
Charlot, L., Sheehan, R., & Hassiotis, A. (2019) · Autism and child psychopathology series · doi:10.1007/978-3-030-20843-1_36 · Cited by 2
Ghaly, A. S., Tobar, S., El-Hadidy, M. A., & Elwasify, M. (2020) · Middle East Current Psychiatry · doi:10.1186/s43045-020-00056-7 · Cited by 2
Alshawwa, S. Z., Alarnous, R., & Albasalah, A. (2023) · Periodicals of Engineering and Natural Sciences (PEN) · doi:10.21533/pen.v11i2.3506 · Cited by 2
Charlot, L. (2016) · Springer eBooks · doi:10.1007/978-3-319-18096-0_131 · Cited by 2
Ethical Considerations Regarding Treatment
Cervantes, P. E., Matson, J. L., Matheis, M., & Burns, C. O. (2017) · Autism and child psychopathology series · doi:10.1007/978-3-319-61738-1_3 · Cited by 2
Effective Medications for Treating Individuals with Autism Spectrum Disorder
Farmer, C., Leon, J., & Hommer, R. E. (2019) · Pediatric school psychology · doi:10.1007/978-3-030-15541-4_6 · Cited by 2
Perumal, V., & Lekhra, O. (2017) · SSRN Electronic Journal · doi:10.5281/zenodo.848318 · Cited by 2
Big data approaches to investigating Child Mental Health disorder outcomes
Downs, J. M. (2018) · Research Portal (King's College London) · Cited by 2
ASD Diagnosis in Adults: Phenotype and Genotype Findings from a Clinically-derived CohortPreprint
Underwood, J. F. G., Kendall, K. M., Berrett, J., Anney, R., van den Bree, M. B. M., & Hall, J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/420778 · Cited by 2
Khanna, R. (2010) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.4618 · Cited by 2
Emerging Research towards the Understanding and Treatment of Autism
Wang, P. P., Hammond, R., Postma, F. R., & Healy, A. M. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00384 · Cited by 1
Global pharmaceutical care approaches to autism spectrum disorder: a scoping review protocol
Sape, R. M., Shead, D. A., & Maseko, B. C. (2024) · JBI Evidence Synthesis · doi:10.11124/jbies-23-00247 · Cited by 1
Durham, H. S., Bowman, K. L., & Harrison, A. J. (2024) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-129.6.490 · Cited by 1
Aiyeolemi, A. A., Amaeze, O. U., Okugbeni, V., Kehinde, O., Adeleke, A. A., & Barner, J. C. (2024) · Health Services Insights · doi:10.1177/11786329241299314 · Cited by 1
Ponnou, S., Briffault, X., Thomé, B., Aragno, V., & Chamak, B. (2025) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/j.neurenf.2025.02.006 · Cited by 1
Li, W., Bao, C., Ye, Y., Liu, Q., Chu, K., Wang, Y., Ruan, X., Lü, H., Liu, X., & Ke, X. (2025) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-025-06779-y · Cited by 1
Setién-Ramos, I., Alonzo-Castillo, T., García-Martínez, A., Lugo‐Marín, J., Martínez-Ramírez, M., Ramos‐Quiroga, J. A., & Gisbert, L. (2025) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2025.100319 · Cited by 1
Tarroso, M., Almeida, J., Lontro, R., Marques, C., S Miguel, T., Lobo, C., Café, C., Mouga, S., Lapa, L., Duque, F., et al. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.25754/pjp.2010.4356 · Cited by 1
Medication and nutritional treatments for children with ASDs
Mehta, S. U., Siragavarapu, R. R., & Reber, M. E. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511978616.012 · Cited by 1
Measuring the Effects of Medication for Individuals with Autism
Zarcone, J. R., Griffith, A. K., & Rieken, C. J. (2018) · Springer eBooks · doi:10.1007/978-3-030-03213-5_5 · Cited by 1
Thapliyal, A., Suri, K., Chauhan, R., Murugan, N. A., & Maurya, S. K. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01467-9 · Cited by 1
Zappia, K. J., & Erickson, C. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-78143-8_12 · Cited by 1
Perspectives of South Korean Parents Toward Psychotropic Medication Use Among Autistic Individuals
Kim, K. M., Lee, C. E., Park, Y., Han, K., & Cho, I. Y. (2025) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-025-06821-z · Cited by 1
Strategies for Treatment of Autistic Dental Patients
Rada, R. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_131 · Cited by 1
Several Issues Differentiate MH Care in Rural, Urban Youth
Levin, A. R. (2013) · Psychiatric News · doi:10.1176/appi.pn.2013.8b10 · Cited by 1
Treatment in autism spectrum disorder
Freeman, S. F. N., & Paparella, T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818466-0.00011-3 · Cited by 1
Psychopharmacology of Autism Spectrum Disorder
Ozdemir, S., Keary, C. J., Joshi, G., Ceranoglu, A. T., & McDougle, C. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-46295-6_25 · Cited by 1
Sheffield, K. (2014) · Louisiana State University · doi:10.31390/gradschool_dissertations.3219 · Cited by 1
Heady, N., Watkins, A. J., John, A. M., & Hutchings, H. A. (2023) · Research Square · doi:10.21203/rs.3.rs-3344908/v1 · Cited by 1
Quality of Life and Physical Well-Being in People with ASDs
Nieto, C., & Ventoso, R. (2011) · InTech eBooks · doi:10.5772/22121
Teplin, S. W., Macias, M. M., Mansoor, E., & Murray, K. E. (2009) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e31819cf544
Kuwabara, H., Kono, T., Shimada, T., & Kano, Y. (2011) · Brain and Development · doi:10.1016/j.braindev.2011.01.003
A Reevaluation of the State of Autism Treatment
London, E. (2009) · CRC Press eBooks · doi:10.1201/9781420068870-c19
Pharmakologische Therapieoptionen in der psychiatrischen Versorgung
Duketis, E. (2014) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-013-0577-9
Zarrabi, S. (2013) · OakTrust (Texas A&M University Libraries)
An Awareness of Asperger’s Syndrome Subcultures as an Answer to Surplus Suffering
Romanik, V., & Sperling, B. (2018) · INvoke · doi:10.29173/invoke48961
Development of the Interdisciplinary Treatment Team
Raches, C. M., Keehn, R. M., Fodstad, J. C., & Minshawi, N. F. (2019) · Autism and child psychopathology series · doi:10.1007/978-3-030-13027-5_10
Pragmatic language in autism and fragile X syndrome: links with physiological arousal and anxiety
Klusek, J. (2012) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/n8n8-g904 · Cited by 1
How can pharmacotherapy impact the quality of life of individuals with high functioning autism?
Montrenes, J. J., & Matson, J. L. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1663824
An empirical evaluation of executive function in Autism Spectrum Disorder
Demetriou, E. (2018) · The Sydney eScholarship Repository (The University of Sydney)
Utilisation and outcomes of treatment in Autism Spectrum Disorder
Houghton, R. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210304rh
Cumpanasoiu, D. C. (2020) · Digital Repository Service (Northeastern University) · doi:10.17760/d20385585
Pharmacological Therapies in Children and Adolescents
Abbas, M., Shah, A., Truong, A. L., Thomas, J. D., Saxena, K., & Calarge, C. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00048-0
Autism spectrum disorder and sleep: pharmacology management
Ballester, P., & Peiró, A. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822822-7.00002-8
Teplin, S. W., Macias, M. M., & Mansoor, E. (2008) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e31817f2c46
Deb, S. S., Roy, M., Limbu, B., & Bertelli, M. O. (2022) · Autism and child psychopathology series · doi:10.1007/978-3-030-88538-0_50
The impact of epilepsy on the overall development of children with autism spectrum disorders
Skrypnyk, T. (2022) · Ukrains kyi Visnyk Psykhonevrolohii · doi:10.36927/2079-0325-v30-is2-2022-10
ASPECTOS GENÉTICOS DO TRANSTORNO DO ESPECTRO AUTISTA (TEA)
de Andrade, M. D. F. C., Carvalho, E. D. F., & Carvalho, K. D. M. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tea2232-12
Porcino, J. M. A., & Vasconcelos, G. C. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tea2232-6
Moreira, M. D. S., & Aragão, G. F. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tea2232-1 · Cited by 31
Porcino, J. M. A., Pinheiro, N. M., Souza, T. M. D. S. F., Soares, C. C. A., de Lima, M. A., & Filho, V. D. D. S. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tea2232-24
TEA LEVE: ANTIGA SINDROME DE ASPERGER
de Carvalho, B. M. M., Ferreira, L. E. A., Simão, S. E., Ribeiro, L. D. S., Sousa, M. C., Los, M. E., Lobato, C. P., & de Carvalho, A. V. A. M. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tea2232-10
TRANSTORNO DO ESPECTRO AUTISTA E DIAGNÓSTICO POR IMAGEM
Morais, Y. B., Felix, L. D. C., & Oliveira, S. D. R. C. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tea2232-21
DIETAS ISENTAS DE GLÚTEN E CASEÍNA EM CRIANÇAS E ADOLESCENTES COM TEA
Vasconcelos, Q. D. J. S. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tea2232-30
METILAÇÃO DO DNA ENVOLVIDA NA EXPRESSÃO DO TRANSTORNO DO ESPECTRO AUTISTA
Maia, D. O., Alves, A. D. S., Guimarães, S. C. M., Rocha, I. G. B., ALBUQUERQUE, G. B. D., & Aragão, G. F. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tea2232-13
Weir, P. A., Tevis, C. M., & Matson, J. L. (2023) · Autism and child psychopathology series · doi:10.1007/978-3-031-24926-6_25
Raitez, S. R., Souza, T. P. D., Oliveira, R. T. D., Nascif, J. V. C., Culau, M. V., Teixeira, A. R., Orben, M. C., da Silva, F. D., Amaral, E. S., Brito, C. R., et al. (2023) · International Journal of Health Science · doi:10.22533/at.ed.15938923231010
Chapter 66. Treatment of Autism Spectrum Disorder
Hegarty, J. P., & Hardan, A. Y. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as66
New Insights on Challenging Behavior: Assessment and Treatment Across the Lifespan
Hassiotis, A., & Vegh, B. (2024) · Autism and child psychopathology series · doi:10.1007/978-3-031-66902-6_9 · Cited by 2
Hartley-McAndrew, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15682-3.00008-0
A Medical Neighborhood Model for Chronic Autism Care: A Compassionate Systems Perspective
Cameron, M. J., Lipschultz, J. L., Yang, Z., & Arabian, M. (2024) · Autism and child psychopathology series · doi:10.1007/978-3-031-64499-3_9
Shogar, A. E., Shayoup, M. E., & Umar, M. S. (2024) · Student s Journal of Health Research Africa · doi:10.51168/sjhrafrica.v5i12.1457
Cognitive Enhancement and Brain Plasticity in Mental Health
West, H. V., Finnegan, M. K., Marder, M. A., Richier, C., Miller, G. A., & Heller, W. (2025) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197677131.013.14
Estudillo‐Guerra, M. A., Teixeira, P. E. P., Martínez, D., Herbert, M. R., & Morales-Quezada, L. (2025) · Research Square · doi:10.21203/rs.3.rs-6363364/v1
Ni, S.-Y., Lu, C., Wu, C., Hsieh, M.-H., Chen, I., Lin, C., Lai, F., & Chien, Y. (2025) · doi:10.2196/preprints.76381
Dataset of pharmacotherapy in autism spectrum disorder
Neto, S. G. D. B., de Araújo, C. O., Reis, R. D. C., Almeida, K. J., Brunoni, D., & Cysneiros, R. M. (2025) · Data in Brief · doi:10.1016/j.dib.2025.111802
Mood Stabilizers and Antiepileptics
Deb, S. S., Roy, M., & Limbu, B. (2025) · Oxford University Press eBooks · doi:10.1093/oso/9780197635841.003.0029
Optimizing Inpatient Care for Children with Neurodevelopmental Disabilities
Seabury, A., Pipan, M. E., Blum, N. J., & Campbell, K. M. (2025) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2025.114902
Ballinger, K., Kim, S. J., Rockhill, C., & Taniguchi, E. (2025) · Research in Autism · doi:10.1016/j.reia.2025.202748
Psychotropic Medications as Treatments for People with Autism Spectrum Disorders
Li, A., Poling, A. D., & Ehrhardt, K. E. (2025) · Autism and child psychopathology series · doi:10.1007/978-3-032-01237-1_16
Psychotropic medication use and health-related behaviors in adults with autism spectrum disorder
Drumond, M. R., Santos, J. D., Macedo, M. T. S., Baldo, T. D. O. F., & Baldo, M. P. (2026) · International Journal of Developmental Disabilities · doi:10.1080/20473869.2026.2671192
Therapy and Antidepressant Use in 8- to 29-Year-Old Autistic Medicaid Enrollees With Depression
Carey, M. E., Holmes, L. G., Shea, L., Mandell, D. S., Schendel, D., Lee, B. K., & Lyall, K. (2026) · Autism · doi:10.1177/13623613261453106
Self-citation
Metadata
- Authors
- Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E.
- Affiliations
- Leonard Davis Institute of Health Economics (US)
- University of Pennsylvania (US)
- Rady Children's Hospital-San Diego (US)
- ORCID
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2008-03-01
- Volume
- 121
- Issue
- 3
- Pages
- e441-e448
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- PMC
- PMC2861431
- OpenAlex
- W1980023413
- Cited by
- 295
- References
- 49
- Citations by year
- 2026: 2 · 2025: 17 · 2024: 17 · 2023: 14 · 2022: 20 · 2021: 21 · 2020: 16 · 2019: 16 · 2018: 19 · 2017: 14 · 2016: 19 · 2015: 15 · 2014: 16 · 2013: 35 · 2012: 18
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Pennsylvania
- National Institute of Mental Health (R01MH077000)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- psychotropic drug use, autism spectrum disorder, Medicaid, children, antipsychotic drugs, antidepressants, stimulants, prescribing patterns, foster care, county-level factors, racial and ethnic disparities, urban density
- MeSH terms
- Adolescent, Age Factors, Attitude of Health Personnel, Autistic Disorder, Mental Disorders, Child, Child, Preschool, Cross-Sectional Studies, Drug Utilization, Eligibility Determination, Female, Follow-Up Studies, Humans, Male, Medicaid, Practice Patterns, Physicians', Probability, Psychotropic Drugs, Retrospective Studies, Sex Factors, Multicenter Studies as Topic, Incidence, Multivariate Analysis, Treatment Outcome, Risk Assessment, Asperger Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review